Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.
- Presentation
Cosmetic and Regenerative Procedures for Hair Loss: PRP, Exosomes, Lasers, and Scalp Health
Description
The talk reviewed cosmetic and regenerative options for hair loss, emphasizing that many patients want aesthetic improvement even when regrowth is limited. Platelet-rich plasma (PRP) was described as an off-label option for androgenetic alopecia and some scarring alopecias, though preparation is variable, evidence is uneven, and benefits appear most convincing when there is a strong pattern hair loss component. Practical points included baseline labs, scalp cleanliness, hydration, and avoiding anticoagulants when possible. Exosomes were presented as promising but not yet supported by strong data or FDA-approved injectable products; most marketed products are actually secretomes or mixed cocktails, with concerns about donor screening, contamination, and marketing claims. Photobiomodulation/low-level light therapy was described as FDA-cleared for androgenetic alopecia, generally safe, but highly dependent on adherence and less well validated in scarring alopecia and darker skin types. Other energy-based and procedural options included various laser platforms, ultrasound/growth factor devices with limited published evidence, and a newer micro-channel laser that may be better tolerated than PRP but still lacks data for scarring alopecia. The speaker also discussed hair transplantation, noting longer quiescent periods for scarring disease, lower graft survival in FFA, and caution with international procedures. Finally, scalp health and “head spa” services were highlighted as a growing industry, with interest in hydrodermabrasion, microbiome effects, and patient experience, but with limited standardization. Microneedling and home devices were approached cautiously, especially in scarring alopecia due to inflammation and risk of adverse reactions. Cosmetic pearls for FFA included addressing facial papules, dyschromia, and volume loss, while warning against filler-related alopecia, deep chemical peels, and fully ablative procedures in scarring alopecia.
View moreConclusions
- For scarring alopecias, procedural and cosmetic interventions may help stabilize disease and improve appearance, but they are generally adjuncts rather than true cures for hair regrowth.
- PRP appears promising and fairly safe, yet its preparation is highly variable and the evidence in scarring alopecia remains limited, with better results seeming most likely when androgenetic alopecia is also present.
- Exosome-based products are biologically intriguing but remain unsupported by high-quality human data and are not FDA approved for injection, so current clinical use is premature.
- Photobiomodulation is one of the more established device-based options, is generally safe and well tolerated, and may provide modest benefit, but adherence is a major barrier.
- Newer energy-based technologies such as laser, ultrasound, and iontophoresis-based systems are promising but still have insufficient robust evidence, especially for scarring alopecias.
- Hair transplantation can be useful in carefully selected, stable patients, but outcomes are less reliable in frontal fibrosing alopecia and similar scarring disorders.
- Scalp spa and hydrodermabrasion-style services may satisfy patient demand for scalp health and experience, but they are not well standardized and should not be viewed as evidence-based disease treatment.
- Microneedling and other non-invasive delivery methods may have a role, but caution is needed because inflamed or scarring scalps may be at higher risk of irritation or adverse effects.
- Cosmetic management of the face and hairline is an important part of care in scarring alopecia, because treating pigment change, contour loss, and facial aging can meaningfully improve patient satisfaction.
- Overall, the field is moving toward more systematic evidence, but most interventions still require better trials, standardized protocols, and clear safety data before routine endorsement.
- Heterogeneity in amount of growth factors secreted by platelets in platelet-rich plasma samples from alopecia patients. Experimental Dermatology, 2020.#10.1111/exd.14165
- The Physician's Guide to Platelet-Rich Plasma in Dermatologic Surgery Part I: Definitions, Mechanisms of Action, and Technical Specifications. Dermatologic Surgery, 2020.#10.1097/dss.0000000000002147
- Use of Platelet-Rich Plasma in Cicatricial Alopecia.#10.1097/dss.0000000000001618
- Transitory hair growth using platelet-rich plasma therapy in stabilized central centrifugal cicatricial alopecia.#10.1111/dth.15798
- Platelet-rich plasma in alopecia areata and primary cicatricial alopecias: A systematic review.#10.3389/fmed.2022.1058431
- Park BS, Choi HI, Huh G, Kim WS. Effects of exosome from adipose-derived stem cell on hair loss: A retrospective analysis of 39 patients. J Cosmet Dermatol. 2022;21(5):2282-4.#10.1111/jocd.14846
- Effectiveness of Exosome Treatment in Androgenetic Alopecia: Outcomes of a Prospective Study.#10.1007/s00266-025-04689-z
- Exosomes Exposed: Overview Systematic Review on Evidence Versus Expectation in Aesthetic and Regenerative Medicine.#10.1007/s00266-024-04276-8
- Regenerative Medicine for Hair Health: From Principles to Practice (Part II). JAAD CME article.#10.1016/j.jaad.2026.01.060
- Alessandrini AM et al. Dermatol Pract Concept. 2021 May 20;11(3):e2021082. doi: 10.5826/dpc.1103a82. PMID: 34123571; PMCID: PMC8172030.#10.5826/dpc.1103a82
- Hair transplant in frontal fibrosing alopecia: A multicenter review of 51 patients. 2019 Sep;81(3):865-866. doi: 10.1016/j.jaad.2019.05.031. Epub 2019 Jul 23.#10.1016/j.jaad.2019.05.031
- Characterization and treatment of prominent facial vasculature in the setting of frontal fibrosing alopecia.#10.1016/j.jaad.2021.12.051
- Microneedling and Its Use in Hair Loss Disorders: A Systematic Review. Dermatol Ther (Heidelb), 2022.#10.1007/s13555-021-00653-2
- Dermal Filler-Induced Alopecia: A Case Report and Literature Review. PMID 39563609, PMCID PMC11845928, DOI 10.1111/jocd.16684.#10.1111/jocd.16684
- Frontal fibrosing alopecia—A new absolute contraindication for deep chemical peels. Clin Dermatol. 2024 Nov-Dec;42(6):696-700.#10.1016/j.clindermatol.2024.06.024